,Chapter c1: cIntroduction cto
cPathophysiologycTest cBank
MULTIPLE
cCHOICE
1. C.Q. cwas crecently cexposed cto cgroup cA chemolytic cStreptococcus cand csubsequently cdeveloped ca cpharyn
cexamination creveals can coral ctemperature cof c102.3° cF, cskin crash, cdysphagia, cand creddened cthroat c
cpustules. cHeccomplains cof csore cthroat, cmalaise, cand cjoint cstiffness. cA cthroat cculture cis cpositive cfo
cantibiotics chave cbeen cprescribed. cThe cetiology cof cC.Q.‟s cdisease cis
a. a csore cthroat.
b. streptococcal cinfection.
c. genetic csusceptibility.
d. pharyngitis.
ANS: c B
Etiology crefers cto cthe cproposed ccause cor ccauses cof ca cparticular cdisease cprocess. cA csore cthroat cis
cdisease cprocess. cGenetic csusceptibility crefers cto can cinherited ctendency cto cdevelop ca cdisease. cPha
cinflammation cof cthe cthroatcandis calso ca cclinical cmanifestation cof cthe cdisease cprocess.
REF: cPg. c2
2. A c17-year-old ccollege-bound cstudent creceives ca cvaccine cagainst can corganism cthat ccauses cmeningi
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c A
Primary cprevention cis cthe cprevention cof cdisease cby caltering csusceptibility cor creducing cexposure cf
cindividualsby cprovidingvaccination. cSecondary cprevention cis cthe cearly cdetection, cscreening, cand cm
cdisease. cTertiary cpreventioncincludes crehabilitative cand csupportive ccare cand cattempts cto calleviate c
ceffective cfunctioning. cDisease ctreatmentcinvolves cmanagement cof cthe cdisease conce cit chas cdevelop
REF: cPg. c9
3. An cobese cbut cotherwise chealthy cteen cis cgiven ca cprescription cfor ca clow-calorie cdiet cand cexercise cp
cof
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c B
Secondary cprevention cis cthe cearly cdetection, cscreening, cand cmanagement cof cthe cdisease csuch cas cp
cexercise cfor cancindividual cwho chas calready cdeveloped cobesity. cPrimary cprevention cis cthe cpreventi
csusceptibility cor creducing cexposure cfor csusceptible cindividuals. cTertiary cprevention cincludes creha
ccare cand cattempts cto calleviate cdisability cand crestore ceffective cfunctioning. cDisease ctreatment cinvo
cthe cdisease conce cit chas cdeveloped.
REF: cPgs. c9-10
4. A cpatient cwith chigh cblood cpressure cwho cis cotherwise chealthy cis ccounseled cto crestrict csodium cinta
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c B
, 6. A cpatient chas cbeen cexposed cto cmeningococcal cmeningitis, cbut cis cnot cyet cdemonstrating csigns cof ct
cof cillness cisccalled cthe stage.
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: c B
Incubation crefers cto cthe cinterval cbetween cexposure cof ca ctissue cto can cinjurious cagent cand cthe cfirst
csymptoms.cIn cinfectious cdiseases, cthis cperiod cis coften ccalled cthe cincubation c(latent) cperiod. cProdro
cappearance cof cthe cfirst csignscand csymptoms cindicating cthe conset cof ca cdisease. cThese care coften cno
cheadache, cmalaise, canorexia, cand cnausea, cwhich care cassociated cwith ca cnumber cof cdifferent cdisea
csubsequent cpathologic ccondition cresulting cfrom ca cdisease. cConvalescence cis cthe cstage cof crecover
cor csurgical coperation.
REF: cPg. c3
7. A cdisease cthat cis cnative cto ca cparticular cregion cis ccalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
ANS: c B
A cdisease cthat cis cnative cto ca cparticular cregion cis ccalled cendemic. cAn cepidemic cis ca cdisease cthat cs
cindividuals cat cthecsame ctime. cPandemics care cepidemics cthat caffect clarge cgeographic cregions, cperh
REF: cPg. c6
8. In cgeneral, cwith caging, corgan csize cand cfunction
a. increase.
b. decrease.
c. remain cthe csame.
d. is cunknown.
ANS: c B
In cgeneral, cwith caging, corgan csize cand cfunction cdecrease.
REF: cPg. c5
9. The c stage c during c which c the c patient c functions c normally, c although c the c disease c processes c are c we
c as
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: c B
The cstage cduring cwhich cthe cpatient cfunctions cnormally, calthough cthe cdisease cprocesses care cwell c
csubclinicalcstage. cThe cinterval cbetween cexposure cof ca ctissue cto can cinjurious cagent cand cthe cfirst cap
csymptoms cmay cbe ccalledca clatent cperiod cor, cin cthe ccase cof cinfectious cdiseases, can cincubation cperiod.
c or c prodrome, c refers cto c the cappearance cof cthe cfirst csigns cand csymptoms cindicating cthe conset co
cis cthe cstage cof crecovery cafter ca cdisease,cinjury, cor csurgical coperation.
REF: cPg. c3
MULTIPLE cRESPONSE
10. Your c patient‟s c red c blood c cell c is c slightly c elevated c today. c This c might c be c explained c by c(Select c a
, REF: cPgs. c7-8
cPathophysiologycTest cBank
MULTIPLE
cCHOICE
1. C.Q. cwas crecently cexposed cto cgroup cA chemolytic cStreptococcus cand csubsequently cdeveloped ca cpharyn
cexamination creveals can coral ctemperature cof c102.3° cF, cskin crash, cdysphagia, cand creddened cthroat c
cpustules. cHeccomplains cof csore cthroat, cmalaise, cand cjoint cstiffness. cA cthroat cculture cis cpositive cfo
cantibiotics chave cbeen cprescribed. cThe cetiology cof cC.Q.‟s cdisease cis
a. a csore cthroat.
b. streptococcal cinfection.
c. genetic csusceptibility.
d. pharyngitis.
ANS: c B
Etiology crefers cto cthe cproposed ccause cor ccauses cof ca cparticular cdisease cprocess. cA csore cthroat cis
cdisease cprocess. cGenetic csusceptibility crefers cto can cinherited ctendency cto cdevelop ca cdisease. cPha
cinflammation cof cthe cthroatcandis calso ca cclinical cmanifestation cof cthe cdisease cprocess.
REF: cPg. c2
2. A c17-year-old ccollege-bound cstudent creceives ca cvaccine cagainst can corganism cthat ccauses cmeningi
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c A
Primary cprevention cis cthe cprevention cof cdisease cby caltering csusceptibility cor creducing cexposure cf
cindividualsby cprovidingvaccination. cSecondary cprevention cis cthe cearly cdetection, cscreening, cand cm
cdisease. cTertiary cpreventioncincludes crehabilitative cand csupportive ccare cand cattempts cto calleviate c
ceffective cfunctioning. cDisease ctreatmentcinvolves cmanagement cof cthe cdisease conce cit chas cdevelop
REF: cPg. c9
3. An cobese cbut cotherwise chealthy cteen cis cgiven ca cprescription cfor ca clow-calorie cdiet cand cexercise cp
cof
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c B
Secondary cprevention cis cthe cearly cdetection, cscreening, cand cmanagement cof cthe cdisease csuch cas cp
cexercise cfor cancindividual cwho chas calready cdeveloped cobesity. cPrimary cprevention cis cthe cpreventi
csusceptibility cor creducing cexposure cfor csusceptible cindividuals. cTertiary cprevention cincludes creha
ccare cand cattempts cto calleviate cdisability cand crestore ceffective cfunctioning. cDisease ctreatment cinvo
cthe cdisease conce cit chas cdeveloped.
REF: cPgs. c9-10
4. A cpatient cwith chigh cblood cpressure cwho cis cotherwise chealthy cis ccounseled cto crestrict csodium cinta
a. primary cprevention.
b. secondary cprevention.
c. tertiary cprevention.
d. disease ctreatment.
ANS: c B
, 6. A cpatient chas cbeen cexposed cto cmeningococcal cmeningitis, cbut cis cnot cyet cdemonstrating csigns cof ct
cof cillness cisccalled cthe stage.
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: c B
Incubation crefers cto cthe cinterval cbetween cexposure cof ca ctissue cto can cinjurious cagent cand cthe cfirst
csymptoms.cIn cinfectious cdiseases, cthis cperiod cis coften ccalled cthe cincubation c(latent) cperiod. cProdro
cappearance cof cthe cfirst csignscand csymptoms cindicating cthe conset cof ca cdisease. cThese care coften cno
cheadache, cmalaise, canorexia, cand cnausea, cwhich care cassociated cwith ca cnumber cof cdifferent cdisea
csubsequent cpathologic ccondition cresulting cfrom ca cdisease. cConvalescence cis cthe cstage cof crecover
cor csurgical coperation.
REF: cPg. c3
7. A cdisease cthat cis cnative cto ca cparticular cregion cis ccalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
ANS: c B
A cdisease cthat cis cnative cto ca cparticular cregion cis ccalled cendemic. cAn cepidemic cis ca cdisease cthat cs
cindividuals cat cthecsame ctime. cPandemics care cepidemics cthat caffect clarge cgeographic cregions, cperh
REF: cPg. c6
8. In cgeneral, cwith caging, corgan csize cand cfunction
a. increase.
b. decrease.
c. remain cthe csame.
d. is cunknown.
ANS: c B
In cgeneral, cwith caging, corgan csize cand cfunction cdecrease.
REF: cPg. c5
9. The c stage c during c which c the c patient c functions c normally, c although c the c disease c processes c are c we
c as
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: c B
The cstage cduring cwhich cthe cpatient cfunctions cnormally, calthough cthe cdisease cprocesses care cwell c
csubclinicalcstage. cThe cinterval cbetween cexposure cof ca ctissue cto can cinjurious cagent cand cthe cfirst cap
csymptoms cmay cbe ccalledca clatent cperiod cor, cin cthe ccase cof cinfectious cdiseases, can cincubation cperiod.
c or c prodrome, c refers cto c the cappearance cof cthe cfirst csigns cand csymptoms cindicating cthe conset co
cis cthe cstage cof crecovery cafter ca cdisease,cinjury, cor csurgical coperation.
REF: cPg. c3
MULTIPLE cRESPONSE
10. Your c patient‟s c red c blood c cell c is c slightly c elevated c today. c This c might c be c explained c by c(Select c a
, REF: cPgs. c7-8
